Burden of type 2 diabetes in Mexico: Past, current and future prevalence and incidence rates

Preventive Medicine

Volumn 81, Issue , 2015, Pages 445-450

  Meza, Rafael ^a   Barrientos Gutierrez, Tonatiuh ^b   Rojas Martinez, Rosalba ^b   Reynoso Noverón, Nancy ^c   Palacio Mejia, Lina Sofia ^b   Lazcano Ponce, Eduardo ^b   Hernández Ávila, Mauricio ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Age period cohort models; Age specific diabetes incidence; Diabetes incidence and prevalence; Diabetes projections; Markov simulation models

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DIETARY INTAKE; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE POLICY; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SELF REPORT; SEX RATIO; TREND STUDY; DIABETES MELLITUS, TYPE 2; ECONOMICS; FORECASTING; INCIDENCE; MARKOV CHAIN; MIDDLE AGED; NUTRITION; POPULATION GROWTH; RISK FACTOR; THEORETICAL MODEL; YOUNG ADULT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MARKOV CHAINS; MEXICO; MIDDLE AGED; MODELS, THEORETICAL; NUTRITION SURVEYS; OBESITY; POPULATION GROWTH; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84947231002     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.10.015     Document Type: Article

References (40)

1. Aguilar-Salinas C.A., Velazquez Monroy O., Gomez-Perez F.J., et al. Characteristics of patients with type 2 diabetes in Mexico: Results from a large population-based nationwide survey. Diabetes Care 2003, 26:2021-2026.
2. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19:716-723.
3. Arredondo A. Costs, quality of care and financial consequences from diabetes in México: Implications to the Health System and to Patients 2012, Nova Sci Publishers, (in press).
4. Barquera S., Campos-Nonato I., Aguilar-Salinas C., Lopez-Ridaura R., Arredondo A., Rivera-Dommarco J. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Glob. Health 2013, 9. (3-8603-9-3).
5. Boyle J.P., Thompson T.J., Gregg E.W., Barker L.E., Williamson D.F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metrics 2010, 8. (29-7954-8-29).
6. Bruno G., Runzo C., Cavallo-Perin P., et al. Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy. Diabetes Care 2005, 28:2613-2619.
7. Burke J.P., Williams K., Haffner S.M., Villalpando C.G., Stern M.P. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001, 24:1573-1578.
8. Carstensen B., Kristensen J.K., Ottosen P., Borch-Johnsen K., Steering Group of the National Diabetes Register The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008, 51:2187-2196.
9. Castro-Rios A., Doubova S.V., Martinez-Valverde S., Coria-Soto I., Perez-Cuevas R. Potential savings in Mexico from screening and prevention for early diabetes and hypertension. Health Aff. 2010, 29:2171-2179.
10. Consejo Nacional de Población, Proyecciones de Población [article online]. Available from, Accessed February 2013. http://www.conapo.gob.mx/es/CONAPO/Proyecciones_de_la_Poblacion_2010-2050.
11. Danaei G., Finucane M.M., Lu Y., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
12. Dirección General de Información en Salud Sistema Nacional de Información en Salud SINAIS. Defunciones [article online]. Available from, Accessed February 2013. http://www.sinais.salud.gob.mx/basesdedatos/defunciones.html.
13. Dommarco J.R. Obesidad en México: recomendaciones para una política de Estado 2012, Universidad Nacional Autónoma de México.
14. ENSANUT: Encuesta Nacional de Salud y Nutrición [article online]. Available from, Accessed 07/22 2013. http://ensanut.insp.mx/.
15. Food, Organization A The State of Food and Agriculture 2013 2013.
16. Gregg E.W., Zhuo X., Cheng Y.J., Albright A.L., Narayan K.M., Thompson T.J. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes Endocrinol. 2014, 2:867-874.
17. Guariguata L., Whiting D., Weil C., Unwin N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res. Clin. Pract. 2011, 94:322-332.
18. Gutiérrez J.P., Rivera-Dommarco J., Shamah-Levy T., et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales 2012, Instituto Nacional de Salud Pública (MX), Cuernavaca, México.
19. Hernandez-Avila M., Gutierrez P., Reynoso-Noveron N. Diabetes mellitus en Mexico. El estado de la epidemia. Salud Publica Mex. 2013, 55. (S1 29-S1 36).
20. Hernandez-Romieu A.C., Elnecave-Olaiz A., Huerta-Uribe N., Reynoso-Noveron N. Analysis of population survey for determining the factors associated with the control diabetes mellitus in Mexico. Salud Publica Mex. 2011, 53:34-39.
21. Holford T.R. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu. Rev. Public Health 1991, 12:425-457.
22. Holford T.R., Levy D.T., McKay L.A., et al. Patterns of birth cohort-specific smoking histories, 1965-2009. Am. J. Prev. Med. 2014, 46:e31-e37.
23. Honeycutt A.A., Boyle J.P., Broglio K.R., et al. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag. Sci. 2003, 6:155-164.
24. Hunt K.J., Gonzalez M.E., Lopez R., Haffner S.M., Stern M.P., Gonzalez-Villalpando C. Diabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites. Ann. Epidemiol. 2011, 21:899-906.
25. Johnson J.A., Balko S.U. Chapter 2. Epidemiological trends of diabetes in Alberta. Alberta Diabetes Atlas 2011 2011, 11-24. Institute of Health Economics, Edmonton. J.A. Johnson (Ed.).
26. Keiding N. Age-specific incidence and prevalence: a statistical perspective. J. R. Stat. Soc. A. Stat. Soc. 1991, 371-412.
27. Keiding N., Holst C., Green A. Retrospective estimation of diabetes incidence from information in a prevalent population and historical mortality. Am. J. Epidemiol. 1989, 130:588-600.
28. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3.
29. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
30. Narayan K.M., Boyle J.P., Thompson T.J., Gregg E.W., Williamson D.F. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007, 30:1562-1566.
31. Palma O., Shamah-Levy T., Franco A., Olaiz G., Mendez-Ramirez I. Metodología 2006, Instituto Nacional de Salud Publica.
32. Reynoso-Noveron N., Mehta R., Almeda-Valdes P., et al. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey. Cardiovasc. Diabetol. 2011, 10. 1-2840-10-1.
33. Rodriguez Bolanos Rde L., Reynales Shigematsu L.M., Jimenez Ruiz J.A., Juarez Marquezy S.A., Hernandez Avila M. Direct costs of medical care for patients with type 2 diabetes mellitus in Mexico micro-costing analysis. Rev. Panam. Salud Publica 2010, 28:412-420.
34. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87:4-14.
35. Siebert U., Alagoz O., Bayoumi A.M., et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med. Decis. Mak. 2012, 32:690-700.
36. UKPDS Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853.
37. Villalpando S., de la Cruz V., Rojas R., et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex. 2010, 52(Suppl. 1):S19-S26.
38. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94:311-321.
39. Zhang P., Zhang X., Brown J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87:293-301.
40. Zhou H., Isaman D.J., Messinger S., et al. A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care 2005, 28:2856-2863.